Notify me when Charles Cherington files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ERNA | Ernexa Therapeutics Inc. | Common Stock, par value $0.005 per share | 37.9% | $8.76M | $4.46M | 41.7M | +104% | Charles Cherington | Jun 9, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|